100 likes | 122 Views
Nasal Lacrimal Stent Market, by Product Type (Bicanalicular Stent and Monocanalicular Stent), by Application (Epiphora, Dacryocystorhinostomy (DCR), and Congenital Nasolacrimal Obstruction) End User (Hospitals and Ophthalmic Surgery Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027<br>
E N D
Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com COVID-19 Impact Tracker
NASAL LACRIMAL STENT MARKET ANALYSIS Nasal Lacrimal Stent Market, by Product Type (Bicanalicular Stent and Monocanalicular Stent), by Application (Epiphora, Dacryocystorhinostomy (DCR), and Congenital Nasolacrimal Obstruction) End User (Hospitals and Ophthalmic Surgery Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Nasal Lacrimal Stent Market- Drivers The nasal lacrimal stent market size is expected to increase over the forecast period owing to ongoing research on products to treat Epiphora and Dacryocystorhinostomy disease conditions. For instance, October 2019, AlonKahana from University of Michigan sponsored a study aimed to evaluate safety and efficacy of the slit stent ii lacrimal stent for treatment of nasolacrimal duct obstruction.
Nasal Lacrimal Stent Market- Restraints Alternative treatment available for epiphora medical conditions is major restraining factor of nasal lacrimal stent market. Most pharmaceuticals companies are focused on developing promising drugs which are indicated for treatment of ophthalmic diseases.
Nasal Lacrimal Stent Market- Regional Analysis On the basis of region, the nasal lacrimal stent market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the nasal lacrimal stent market during the forecast period, as key market players are focused on expanding their presence in the North America region. For instance, in Jan, 2019, FCI Ophthalmics entered an agreement with Carl Zeiss Canada Ltd. regarding the distribution of FCI Ophthalmics' range of lacrimal stents and tubes, which include Crawford & Ritleng, Mini Monoka & new Masterka (monocanicular stent), Bika & Nunchaku (Bicanicular stent) in Canada.
Nasal Lacrimal Stent Market- Competitive Landscape • Key players operating in the nasal lacrimal stent market include FCI Ophthalmics, Kaneka Corporation, Cook Medical LLC., and Sinopsys Surgical, Inc. • Nasal Lacrimal Stent Market- Taxonomy • By Product Type • By Application
Request Sample Report • Download PDF Brochure • Request Customization • Talk to Analyst BUY NOW For Your Reference: https://www.coherentmarketinsights.com/ongoing-insight/nasal-lacrimal-stent-market-3183
About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis
Contact Us Mr. Shah Coherent Market Insights Private Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com
Thank You! Kindly follow CMI Social Media Profiles for the latest company updates FacebookLinkedIn Twitter https://www.coherentmarketinsights.com/